The myocardial uptake of 1251-and '311-antimyosin monoclonal antibody Fab in experimental myocarditis in BALB/c mice induced by encephalomyocarditis virus was studied. The biodistribution of 1251-antimyosin demonstrated that the highest ratio of radioactivity appears in the heart of infected mice on day 14 (the ratio of percent dose per gram for the organ to percent dose per milliliter for blood; 9.75±2.79 vs. 1.27±0.78 at 24 hours in inoculated mice vs. control mice). There was no statistically significant difference between the mean activity ratios of tissues other than the heart in control and inoculated mice. The uptake ratio for the heart increased significantly 3 days after virus inoculation and reached a maximum on day 14 when myocardial lesions were most extensive and prominent. The uptake ratio decreased significantly, but it still remained high compared with controls on day 28 when cellular infiltration had decreased and fibrosis was evident. The scintigraphic images obtained with 13'1-antimyosin monoclonal antibody clearly demonstrated that visualization of the heart in experimental myocarditis was possible 24 hours after administration of radiotracer, and localized activity was still observed in the 48-hour image. We conclude that antimyosin monoclonal antibodies localize selectively in the heart from the acute to subacute stage of viral myocarditis. These findings indicate that antimyosin scintigraphy is a reliable noninvasive method for the evaluation of patients suspected of having myocarditis. (Circulation 1989;79:400-405) M onoclonal antimyosin antibodies have been useful in the in vitro localization of myocardial necrosis.1-3 The mechanism of antimyosin localization in the damaged myocardium is probably related to increased access of macromolecules to intracellular sites after loss of cell membrane integrity.4 Because myocardial necrosis is an obligatory component of myocarditis,5 radiolabeled Fab
M onoclonal antimyosin antibodies have been useful in the in vitro localization of myocardial necrosis.1-3 The mechanism of antimyosin localization in the damaged myocardium is probably related to increased access of macromolecules to intracellular sites after loss of cell membrane integrity.4 Because myocardial necrosis is an obligatory component of myocarditis,5 radiolabeled Fab of antimyosin monoclonal antibody was used for the diagnosis of myocarditis.6 However, sequential uptake of antimyosin antibody or its histopathologic correlation has not been studied. In this study, we used our experimental model of viral myocarditis7 to investigate sequential myocardial uptake of radioiodinated antimyosin monoclonal antibody Fab, the relation between the uptake and histopathology, and the reliability of scintigraphic imaging.
Methods

Experimental Viral Myocarditis
A murine model of encephalomyocarditis virus was used.7 The virus stock was prepared as previously described.7 Virus stock had a titer of 3 x 106 plaque forming units (PFU) determined in tissue cultures of FL (human amnion) cells. Virus and control fluids were stored at -70o C. Inbred male BALB/c mice were obtained from Shizuoka Agricultural Cooperative Association for Laboratory Animals, Hamamatsu, Japan. This strain has been continuously maintained by brother-sister matings. At 4 weeks of age, mice were inoculated intraperitoneally with 0.1 ml virus suspension containing 300 PFU/0.1 ml. BALB/c mice without inoculation served as the controls. The mice were killed 3 (n = 6), 5 (n = 6), 7 (n = 5), 14 (n = 9), and 28 days (n = 5) after the inoculation.
Preparation ofAntimyosin Monoclonal Antibody
Antimyosin monoclonal antibody R11D10 was obtained as previously described.8 BALB/c mice were immunized with human left ventricular cardiac myosin, and the spleen cells were fused with plasmacytoma cell line Sp2/0-Agl4. The supernatants were screened by solid-phase radioimmunoassay. After purification of antimyosin antibody, Fab was prepared. 
31I-Antimyosin Monoclonal Antibody Imaging
Mice were treated similarly with 0.1% potassium iodine. For myocardial imaging, four control mice and four mice on day 7 after virus inoculation were injected with 200 ,uCi "11-antimyosin in a tail vein. The mice were anesthetized by pentobarbital (0.5 mg/body i.p.), and 24 hours after administering radiotracer, whole-body images were obtained in the posterior view with a gamma camera (PhoGamma LFOV, Searle, Chicago, Illinois) equipped with a pinhole collimator. Fifty thousand counts were accumulated for whole-body images at the energy peak of 364 keV with a 20% window. All scintigrams were interpreted independently by two observers who were unaware of the experimental conditions.
Histopathologic Studies
After the studies of biodistribution and imaging, the hearts were fixed in 10% formalin solution, sectioned transversely at the midportion of the ventricle, embedded in paraffin, and stained with hematoxylin and eosin. Myocardial cell necrosis, cellular infiltration, and calcification were scored blindly by severity on a scale of 1 + to 4+. A 1 + score indicated a limited focal distribution of myocardial lesions. A 4 + score indicated the presence of multiple lesions over the entire heart, whereas scores of 2 + and 3 + indicated intermediate severity.'0
Statistical Analysis
The statistical method used was analysis of variance." Results were expressed as the mean ± SD.
Results
Histopathology
On day 3, histologic abnormality was not evident ( Figure 1A ). Histologic changes were first noted in the myocardium 5 days after inoculation with encephalomyocarditis virus. These changes consisted of focal myocytolysis and a few mononuclear cell infiltrations ( Figure 1B) . On day 7, myocardial necrosis and cellular infiltration were more prominent ( Figure 1C ). Extensive myocardial necrosis with calcification was evident on day 14 ( Figure  1D ). On day 28, cellular infiltration decreased, but myocardial calcification persisted. Myocardial fibrosis was evident at this stage ( Figure 1E ). Scores of myocardial necrosis and cellular infiltration on day 5 (n = 6) were 1.0 ± 0.0 and 1.2 + 0.4, and these significantly increased on day 7 (n = 5) to 2.8 ± 0.4 and 2.4 ± 0.5, respectively (p < 0.001, Figure 2) . Myocardial calcification was prominent on day 14 (1.1±1.5, n=9). Myocardial necrosis and cellular infiltration were less severe on day 28 (n = 5). Mild spontaneous pericardial calcification, which was limited to the right ventricle, was often seen in controls and infected mice and was not included in grading.
Distribution Studies
Biodistribution of 1251-antimyosin in infected mice on day 14 and age-matched control mice 24 hours after administering radiotracer is shown in Figure 3 as percent dose per gram for the organ and the ratio of percent dose per gram for the organ to percent dose per milliliter for blood. Only the heart shows a significantly increased uptake of tracer when compared with either blood or corresponding organs in the control animals. Thus, these findings indicate that localization of antimyosin monoclonal antibody in damaged myocardium primarily reflects specific antigen-antibody interaction. The antimyosin Fab uptake ratio of percent dose per gram for the heart to percent dose per milliliter for blood increased significantly in mice 3 days after inoculation with encephalomyocarditis virus (2.37 ±2.38, p<0.05, compared with 0.65±0.15 of 5-week-old control mice) (Figure 4) . The uptake ratio increased gradually (from 4.12±1.90 on day 5 to 4.87±1.86 on day 7, and it reached a maximum on day 14 of 9.75 ±2.79), and the ratio decreased significantly on day 28 (5.35 + 2.63) but was still elevated when compared with the controls (p<0.05). ' 
311-Antimyosin Imaging
The initial images (at 3 hours) showed blood pool activity, primarily in the viscera. In addition, the thyroid gland and bladder were visualized (not shown). Figure 5 shows a whole-body image in a representative mouse with myocarditis on day 7. The images of the normal mouse, obtained 24 hours after administration of antibody, are shown on the left. Radioactivity is redistributed to the region of the heart, but no '3I activity is seen in the cardiac region of the control animals. Intra-abdominal activity seemed to be due mainly to activity in the stomach. This localized activity in mice with myo technique for detecting acute viral myocarditis in the experimental animal. The '251-antimyosin uptake ratio of the heart began to increase 3 days after virus inoculation when histologic abnormality had not yet appeared. On day 14. the uptake ratio of the heart reached a maximum, and histologically, myocardial lesions were most extensive and prominent at this stage. On day 28, when cellular infiltration had decreased and myocardial fibrosis was evident, the uptake ratio remained elevated. Thus, the increase in 15>I-antimyosin uptake in the early stage of viral myocarditis correlated well with histopathologic changes and persisted long after virus inoculation. These findings suggest that antimyosin scintigraphy is useful for diagnosing viral myocarditis in its subacute to chronic stage and in the acute stage.
A number of laboratory tests can be done to diagnose viral myocarditis, but none is specific. An increased activity of such serum enzymes as creatine kinase, glutamic oxaloacetic transaminase, and lactate dehydrogenase is also common but is seen only during the early stages of the disease. 12 Radionuclide scintigraphic methods for viral myocarditis include 9lmTc-pyrophosphate imaging and 67Ga-citrate imaging. 99mTc-pyrophosphate imaging is useful in the diagnosis of myocardial infarction, and although not specific for myocarditis, sequential study with this technique may help in the diagnosis of viral myocarditis. Although the mechanism by which l9mTc-pyrophosphate accumulates in the damaged myocardium is unknown, it is clear that this agent concentrates selectively in acutely necrotic myocardium irrespective of the cause of the necrosis.13 99mTc-pyrophosphate has also been shown to localize in the myocardium in cases of perimyocarditis in experimental animals and humans. 14, 15 In our experimental model of coxsackievirus myocarditis,14 cardiac uptake of 99mTc-pyrophosphate reached a maximum on day 7 after virus infection but decreased significantly on day 14 when myocardial lesions were most prominent. Thus, 99mTc-pyrophosphate may be useful in diagnosis only in the acute stage of viral myocarditis.
6`Ga-citrate gave positive results in several noncardiac chronic inflammatory diseases characterized by mononuclear cell infiltration. These include lymphoproliferative diseases involving the heart, myocardial abscesses, and bacterial endocarditis. Myocardial 67Ga imaging, though possibly helpful, is not specific for the diagnosis of myocarditis, and scintigrams made In this study, we demonstrated that there is specific and selective localization of antimyosin monoclonal antibody in an experimental model with viral myocarditis. The scintigraphic images obtained with 1311-antimyosin, though the number of animals was small and though the study was preliminary, clearly demonstrate that visualization of the area of damaged myocytes is possible 24 hours after intravenous administration and that this localized activity persists in the 48-hour image. Our data establish that scans with`11-antimyosin should be performed 24-48 hours after radiotracer administration. If imaging is performed earlier than 24 hours, the blood pool radioactivity tends to mask specific cardiac uptake. At 72 hours, cardiac localization is no longer seen in this model.
In conclusion, antimyosin monoclonal antibodies were localized selectively and specifically in damaged myocytes of an experimental model with viral myocarditis. These findings indicate that antimyosin scintigraphy is a reliable noninvasive method for the evaluation of patients suspected of having myocarditis.
